Sunshine Biopharma, Inc·4

Dec 2, 6:01 AM ET

Sebaaly Camille 4

4 · Sunshine Biopharma, Inc · Filed Dec 2, 2022

Insider Transaction Report

Form 4
Period: 2022-11-30
Sebaaly Camille
DirectorCFO and Secretary
Transactions
  • Purchase

    Common Stock

    2022-11-30$0.76/sh+30,000$22,905174,465 total

Documents

1 file
  • 4
    ownership.xmlPrimary